PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Abionyx Pharma SA (ABNX.PA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINFR0012616852
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap€43.72M
EPS (TTM)-€0.10
Total Revenue (TTM)€3.77M
Gross Profit (TTM)€1.49M
EBITDA (TTM)-€2.94M
Year Range€0.91 - €1.48
Target Price€11.50

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in Abionyx Pharma SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%150.00%AprilMayJuneJulyAugustSeptember
-89.76%
166.88%
ABNX.PA (Abionyx Pharma SA)
Benchmark (^GSPC)

Returns By Period

Abionyx Pharma SA had a return of -2.02% year-to-date (YTD) and 11.68% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-2.02%20.30%
1 month-0.63%2.61%
6 months28.78%9.21%
1 year11.68%33.46%
5 years (annualized)32.24%14.17%
10 years (annualized)N/A11.29%

Monthly Returns

The table below presents the monthly returns of ABNX.PA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-3.11%-13.46%-9.26%7.14%19.05%-6.88%6.87%1.77%-2.02%
20239.99%-0.11%20.51%-22.63%-28.34%-1.74%-1.61%-0.98%-7.44%16.96%-0.92%-0.77%-25.20%
2022-6.13%-13.73%12.88%-14.00%-3.75%-21.73%25.83%8.01%-18.19%14.91%-0.00%-6.92%-29.57%
2021-14.56%-0.59%22.14%8.97%31.13%-30.42%8.43%-7.41%-7.13%56.89%107.77%-21.13%147.22%
202022.85%61.59%43.50%0.21%2.49%-13.89%-12.60%18.87%-13.27%-9.67%43.42%-0.20%193.47%
20198.16%-10.94%-24.47%0.56%3.07%-8.25%-7.67%11.82%-12.71%-29.95%50.70%4.50%-31.22%
201827.23%-16.26%-12.53%9.78%0.82%-2.54%6.25%-2.94%-5.96%-12.89%-2.22%-69.10%-74.35%
2017-10.98%0.65%-75.23%-3.65%-6.49%9.83%-8.95%0.00%6.36%9.24%-4.48%-0.52%-77.92%
2016-19.18%5.54%-19.72%0.46%-2.86%-16.71%-2.54%19.86%-12.33%3.31%6.01%8.94%-32.00%
20153.00%-11.26%16.33%-9.99%19.49%-11.77%-1.93%-9.84%13.45%1.92%3.16%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ABNX.PA is 50, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of ABNX.PA is 5050
ABNX.PA (Abionyx Pharma SA)
The Sharpe Ratio Rank of ABNX.PA is 5252Sharpe Ratio Rank
The Sortino Ratio Rank of ABNX.PA is 5151Sortino Ratio Rank
The Omega Ratio Rank of ABNX.PA is 4747Omega Ratio Rank
The Calmar Ratio Rank of ABNX.PA is 4949Calmar Ratio Rank
The Martin Ratio Rank of ABNX.PA is 5252Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Abionyx Pharma SA (ABNX.PA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ABNX.PA
Sharpe ratio
The chart of Sharpe ratio for ABNX.PA, currently valued at 0.33, compared to the broader market-4.00-2.000.002.000.33
Sortino ratio
The chart of Sortino ratio for ABNX.PA, currently valued at 0.89, compared to the broader market-4.00-2.000.002.004.000.89
Omega ratio
The chart of Omega ratio for ABNX.PA, currently valued at 1.10, compared to the broader market0.501.001.501.10
Calmar ratio
The chart of Calmar ratio for ABNX.PA, currently valued at 0.17, compared to the broader market0.002.004.006.000.17
Martin ratio
The chart of Martin ratio for ABNX.PA, currently valued at 1.07, compared to the broader market0.0010.0020.001.07
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.73, compared to the broader market-4.00-2.000.002.002.73
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.64, compared to the broader market-4.00-2.000.002.004.003.64
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.50, compared to the broader market0.501.001.501.50
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.42, compared to the broader market0.002.004.006.002.42
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 16.69, compared to the broader market0.0010.0020.0016.69

Sharpe Ratio

The current Abionyx Pharma SA Sharpe ratio is 0.33. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Abionyx Pharma SA with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AprilMayJuneJulyAugustSeptember
0.33
2.14
ABNX.PA (Abionyx Pharma SA)
Benchmark (^GSPC)

Dividends

Dividend History


Abionyx Pharma SA doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AprilMayJuneJulyAugustSeptember
-91.07%
-1.20%
ABNX.PA (Abionyx Pharma SA)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Abionyx Pharma SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Abionyx Pharma SA was 98.55%, occurring on Oct 25, 2019. The portfolio has not yet recovered.

The current Abionyx Pharma SA drawdown is 91.07%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.55%Jul 31, 20151084Oct 25, 2019
-17.77%Jun 4, 201526Jul 9, 201514Jul 29, 201540
-13.78%Apr 1, 201512Apr 20, 201517May 14, 201529
-4.12%May 15, 20152May 18, 20158May 28, 201510

Volatility

Volatility Chart

The current Abionyx Pharma SA volatility is 10.44%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%AprilMayJuneJulyAugustSeptember
10.44%
4.10%
ABNX.PA (Abionyx Pharma SA)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Abionyx Pharma SA over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Abionyx Pharma SA.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items